There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

Ovarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.

A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new research.

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of ...

Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...

An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at the University of Utah (the U) and Emory University, revealed that Black ...

For months, Ash, 26, could hardly eat and felt so exhausted she could hardly work, so she knew it had to be more than regular bloating.

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with ...

AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx) in women with folate ...

Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically ...

The following is a summary of "Role of MUC16 in tumor biology and tumor immunology in ovarian cancer," published in the ...

Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...